337 related articles for article (PubMed ID: 24036851)
41. Inhibition of protein kinase CK2 by CX-5011 counteracts imatinib-resistance preventing rpS6 phosphorylation in chronic myeloid leukaemia cells: new combined therapeutic strategies.
Salizzato V; Borgo C; Cesaro L; Pinna LA; Donella-Deana A
Oncotarget; 2016 Apr; 7(14):18204-18. PubMed ID: 26919095
[TBL] [Abstract][Full Text] [Related]
42. Combination of all-trans retinoic acid and interferon-gamma suppressed PI3K/Akt survival pathway in glioblastoma T98G cells whereas NF-kappaB survival signaling in glioblastoma U87MG cells for induction of apoptosis.
Zhang R; Banik NL; Ray SK
Neurochem Res; 2007 Dec; 32(12):2194-202. PubMed ID: 17616812
[TBL] [Abstract][Full Text] [Related]
43. Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy.
Kren BT; Unger GM; Abedin MJ; Vogel RI; Henzler CM; Ahmed K; Trembley JH
Breast Cancer Res; 2015; 17():19. PubMed ID: 25837326
[TBL] [Abstract][Full Text] [Related]
44. Inhibition of protein kinase II (CK2) prevents induced signal transducer and activator of transcription (STAT) 1/3 and constitutive STAT3 activation.
Aparicio-Siegmund S; Sommer J; Monhasery N; Schwanbeck R; Keil E; Finkenstädt D; Pfeffer K; Rose-John S; Scheller J; Garbers C
Oncotarget; 2014 Apr; 5(8):2131-48. PubMed ID: 24742922
[TBL] [Abstract][Full Text] [Related]
45. Enhanced antitumor effect of YM872 and AG1296 combination treatment on human glioblastoma xenograft models.
Watanabe T; Ohtani T; Aihara M; Ishiuchi S
J Neurosurg; 2013 Apr; 118(4):838-45. PubMed ID: 23311938
[TBL] [Abstract][Full Text] [Related]
46. Ursolic acid inhibits multiple cell survival pathways leading to suppression of growth of prostate cancer xenograft in nude mice.
Shanmugam MK; Rajendran P; Li F; Nema T; Vali S; Abbasi T; Kapoor S; Sharma A; Kumar AP; Ho PC; Hui KM; Sethi G
J Mol Med (Berl); 2011 Jul; 89(7):713-27. PubMed ID: 21465181
[TBL] [Abstract][Full Text] [Related]
47. Protein kinase CK2 subunits are positive regulators of AKT kinase.
Guerra B
Int J Oncol; 2006 Mar; 28(3):685-93. PubMed ID: 16465374
[TBL] [Abstract][Full Text] [Related]
48. Swelling-induced chloride current in glioblastoma proliferation, migration, and invasion.
Wong R; Chen W; Zhong X; Rutka JT; Feng ZP; Sun HS
J Cell Physiol; 2018 Jan; 233(1):363-370. PubMed ID: 28262948
[TBL] [Abstract][Full Text] [Related]
49. PICT-1 triggers a pro-death autophagy through inhibiting rRNA transcription and AKT/mTOR/p70S6K signaling pathway.
Chen H; Duo Y; Hu B; Wang Z; Zhang F; Tsai H; Zhang J; Zhou L; Wang L; Wang X; Huang L
Oncotarget; 2016 Nov; 7(48):78747-78763. PubMed ID: 27729611
[TBL] [Abstract][Full Text] [Related]
50. CK2 blockade causes MPNST cell apoptosis and promotes degradation of β-catenin.
Kendall JJ; Chaney KE; Patel AV; Rizvi TA; Largaespada DA; Ratner N
Oncotarget; 2016 Aug; 7(33):53191-53203. PubMed ID: 27448963
[TBL] [Abstract][Full Text] [Related]
51. Dual PLK1 and STAT3 inhibition promotes glioblastoma cells apoptosis through MYC.
Wang H; Tao Z; Feng M; Li X; Deng Z; Zhao G; Yin H; Pan T; Chen G; Feng Z; Li Y; Zhou Y
Biochem Biophys Res Commun; 2020 Dec; 533(3):368-375. PubMed ID: 32962858
[TBL] [Abstract][Full Text] [Related]
52. CK2 inhibitor CX-4945 blocks TGF-β1-induced epithelial-to-mesenchymal transition in A549 human lung adenocarcinoma cells.
Kim J; Hwan Kim S
PLoS One; 2013; 8(9):e74342. PubMed ID: 24023938
[TBL] [Abstract][Full Text] [Related]
53. Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival ER chaperone BIP/Grp78 and turning on the pro-apoptotic NF-κB.
Buontempo F; Orsini E; Lonetti A; Cappellini A; Chiarini F; Evangelisti C; Evangelisti C; Melchionda F; Pession A; Bertaina A; Locatelli F; Bertacchini J; Neri LM; McCubrey JA; Martelli AM
Oncotarget; 2016 Jan; 7(2):1323-40. PubMed ID: 26593250
[TBL] [Abstract][Full Text] [Related]
54. Effects of CK2β subunit down-regulation on Akt signalling in HK-2 renal cells.
Alcaraz E; Vilardell J; Borgo C; Sarró E; Plana M; Marin O; Pinna LA; Bayascas JR; Meseguer A; Salvi M; Itarte E; Ruzzene M
PLoS One; 2020; 15(1):e0227340. PubMed ID: 31910234
[TBL] [Abstract][Full Text] [Related]
55. Up-Regulation of the Alpha Prime Subunit of Protein Kinase CK2 as a Marker of Fast Proliferation in GL261 Cultured Cells.
Villamañan L; Alcaraz E; Pinna LA; Ruzzene M; Itarte E; Arús C; Plana M; Candiota AP
Pathol Oncol Res; 2019 Oct; 25(4):1659-1663. PubMed ID: 30607803
[TBL] [Abstract][Full Text] [Related]
56. Druggability of the CK2 inhibitor CX-4945 as an anticancer drug and beyond.
Kim J; Kim SH
Arch Pharm Res; 2012 Aug; 35(8):1293-6. PubMed ID: 22941473
[TBL] [Abstract][Full Text] [Related]
57. Targeting class IA PI3K isoforms selectively impairs cell growth, survival, and migration in glioblastoma.
Höland K; Boller D; Hagel C; Dolski S; Treszl A; Pardo OE; Cwiek P; Salm F; Leni Z; Shepherd PR; Styp-Rekowska B; Djonov V; von Bueren AO; Frei K; Arcaro A
PLoS One; 2014; 9(4):e94132. PubMed ID: 24718026
[TBL] [Abstract][Full Text] [Related]
58. Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signaling.
Buontempo F; Orsini E; Martins LR; Antunes I; Lonetti A; Chiarini F; Tabellini G; Evangelisti C; Evangelisti C; Melchionda F; Pession A; Bertaina A; Locatelli F; McCubrey JA; Cappellini A; Barata JT; Martelli AM
Leukemia; 2014 Mar; 28(3):543-53. PubMed ID: 24253024
[TBL] [Abstract][Full Text] [Related]
59. C-type lectin domain family 5, member A (CLEC5A, MDL-1) promotes brain glioblastoma tumorigenesis by regulating PI3K/Akt signalling.
Fan HW; Ni Q; Fan YN; Ma ZX; Li YB
Cell Prolif; 2019 May; 52(3):e12584. PubMed ID: 30834619
[TBL] [Abstract][Full Text] [Related]
60. c-Jun NH(2)-terminal kinase 2alpha2 promotes the tumorigenicity of human glioblastoma cells.
Cui J; Han SY; Wang C; Su W; Harshyne L; Holgado-Madruga M; Wong AJ
Cancer Res; 2006 Oct; 66(20):10024-31. PubMed ID: 17047065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
